Home
Contact Us
Aggregated China Business Blogs
2021-01-28
Guosen Securities maintains Tiger Pharma's buy rating: the main business continues to recover and non-recurring returns are relatively high
Aggregated Source:
Caishen.Co
Caishen.Co delivers
Primary Data for China`s Secondary Investment and Stock Markets
. Full details at
Caishen.Co
.
Original URL:
Click here to visit original article
Copyright
Caishen.Co
Related Posts
Why Hamish Tadgell just bought back into ResMed
Hard Truths About Europe’s Soft Power
SEC demands more risk disclosure for Chinese companies listing in US
China’s share of global bitcoin electricity usage drops under half
Air passenger demand rises
Talk of more corporate deals sends stocks higher
Chinese EV battery maker soars on debut
China under pressure, a debate
Banking business leaves Ping An exposed to China market turmoil
Zero-Covid: China’s year of forgetting
SEARCH
Browse News
January 2021
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Dec
Feb »
Useful Sites
China Media Blog
China Legal Blog
China Travel Blog
Caishen.Co
ChinaPulse.com
ZhongjintouX.com